Invesaro

Stocks Health care ICLR

NASDAQ · Health care

Icon PLC (ICLR)

Icon PLC reported revenue of $8.3B in fiscal 2025, up 0.8% from a year earlier. Net income was $229.3M, a net margin of 2.8%. Operating cash flow minus capital spending left $862M of free cash flow in fiscal 2025. At December 31, 2025 it held $647.3M in cash against $2.9B of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on May 27, 2026.

Free, no password. An email when ICLR files with the SEC.

Price
$203.69
-1.88% on the day · November 10, 2026
52-week range $66.57 to $219.04
Market cap
$15.6B
Revenue (FY2025)
$8.3B
+0.8% year on year
Net margin
2.8%

Key facts about Icon PLC

Net worth
Icon PLC has a market value (market cap) of $15.6B at the latest share price, and shareholders' equity of $9.2B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $8.3B (+0.8% year on year), with net income of $229.3M.
Cash flow
In fiscal 2025 operations brought in $1B of cash; after $174.2M of capital spending, free cash flow was $862M.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on May 27, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Icon PLC does

Icon PLC is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker ICLR.

Revenue and profit by year

Revenue
FY18: $2.6B $2.6B FY18FY19: $2.8B $2.8B FY19FY20: $2.8B $2.8B FY20FY21: $5.5B $5.5B FY21FY22: $7.7B $7.7B FY22FY23: $8.1B $8.1B FY23FY24: $8.2B $8.2B FY24FY25: $8.3B $8.3B FY25
Net income
FY18: $322.7M $322.7M FY18FY19: $374M $374M FY19FY20: $332.3M $332.3M FY20FY21: $153.2M $153.2M FY21FY22: $505.3M $505.3M FY22FY23: $554.2M $554.2M FY23FY24: $739.1M $739.1M FY24FY25: $229.3M $229.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$8.3B$442.8M$229.3M$2.90$862M
2024$8.2B$1B$739.1M$8.90$1.1B
2023$8.1B$904.7M$554.2M$6.70$1B
2022$7.7B$795.2M$505.3M$5.55$421.2M
2021$5.5B$378.5M$153.2M$2.04$735.4M
2020$2.8B$391.5M$332.3M$5.57$527.2M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where ICLR ranks in Health care

Revenue$8.3B
#52 of 751 in Health care · Top 7%
Revenue growth+0.8%
#401 of 532 in Health care · Bottom 25%
Net margin2.8%
#185 of 544 in Health care · Top 34%
Free cash flow margin10.4%
#125 of 490 in Health care · Top 25%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Icon PLC has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 5, 2026
  2. October 27, 2026
  3. October 27, 2026
  4. October 8, 2026
  5. September 9, 2026
  6. August 20, 2026
  7. August 18, 2026
  8. August 13, 2026
  9. August 6, 2026
  10. August 6, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 4, 2026. Insider transactions on SEC

Insider trades

What the people running Icon PLC did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $4.5M worth of shares in the last 90 days and bought none on the open market.

Bought (open market)
$0
last 90 days
Sold
$4.5M
last 90 days
Net sold
23,916
$4.5M
DateInsiderWhatSharesPriceValueFiling
November 2, 2026 Murray CiaranDirector Sold 3,452 $205.67 $710K Form 4
November 2, 2026 Clerkin Nigel Bernard JohnChief Financial Officer Sold 303 $204.91 $62.1K Form 4
November 2, 2026 Clerkin Nigel Bernard JohnChief Financial Officer Sold 434 $206.15 $89.5K Form 4
November 2, 2026 Clerkin Nigel Bernard JohnChief Financial Officer Sold 352 $207.16 $72.9K Form 4
November 2, 2026 Clerkin Nigel Bernard JohnChief Financial Officer Sold 377 $208.00 $78.4K Form 4
November 2, 2026 Clerkin Nigel Bernard JohnChief Financial Officer Sold 22 $209.53 $4.6K Form 4
November 2, 2026 Lyons EmerChief Accounting Officer Sold 54 $204.91 $11.1K Form 4
November 2, 2026 Lyons EmerChief Accounting Officer Sold 76 $206.15 $15.7K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns ICLR

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Artisan Partners Asset Management Inc.13G, passive with 4 related filers 10.9% 8,361,303 March 6, 2026
Wellington Management Group LLP13G, passive with 3 related filers 7.7% 5,913,037 May 15, 2026
Fmr LLC13G, passive with 1 related filers 6.9% 5,271,321 August 6, 2026
Harris Associates L P13G, passive with 1 related filers 5.7% 4,351,317 May 15, 2026

Latest filings below 5%: Orbis Investment Management Ltd 0% (May 15, 2026); WCM Investment Management, LLC 0.25% (July 3, 2025); Massachusetts Financial Services Company ("MFS") 4.9% (November 12, 2024).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

10 insiders reported holding 54,992 shares in total, about $11.2M at the last price.

HolderSharesAs of
Murray CiaranDirector 17,000 November 2, 2026
Balfe Barry EdwardChief Executive Officer, Director 9,291 November 2, 2026
Clerkin Nigel Bernard JohnChief Financial Officer 7,171 November 2, 2026
Grais LindaDirector 6,162 August 11, 2026
Murphy Ronan MartinDirector 3,847 September 17, 2026
McCague Eugene PacelliDirector 3,811 September 17, 2026
O'Neill JulieDirector 3,515 August 11, 2026
Climax John DrDirector 2,087 September 16, 2026
Lyons EmerChief Accounting Officer 1,217 November 2, 2026
Whitaker Anne ClemDirector 891 August 11, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ICLR

What does Icon PLC do?

Icon PLC is a company in the Health care sector, listed on NASDAQ as ICLR. Its shares trade on NASDAQ under the ticker ICLR.

What is Icon PLC's net worth?

Icon PLC has a market value (market cap) of $15.6B at the latest share price, and shareholders' equity of $9.2B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Icon PLC profitable?

Yes. In fiscal 2025 it reported net income of $229.3M on revenue of $8.3B, a net margin of 2.8%.

How much revenue does Icon PLC make?

In fiscal 2025 Icon PLC reported revenue of $8.3B. That is 0.8% more than a year earlier.

When did Icon PLC last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on May 27, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the passive stake changed from November 5, 2026.

Similar companies

Compare ICLR with

Compare ICLR with any company

Follow ICLR

Get an email when Icon PLC files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when ICLR files with the SEC.

Where the numbers come from

Financial figures are the values Icon PLC tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.